MAM
Mobil becomes performance sponsor for Indian Racing Festival 2024 edition
Mumbai: The Indian Racing Festival (IRF) has onboarded Mobil, a name in the world of motor oils, as the performance sponsor for the 2024 season. This collaboration will see high-performance engine oils of Mobil elevating the fast-growing motorsport sector by powering the high-speed cars of the IRF with their advanced lubricants, delivering unmatched performance and reliability as the six teams in the Indian Racing League (IRL) and eight teams in the Formula four Indian Championship (F4IC) will be competing against each other.
Powered by Mobil 1 5w – 40, a full synthetic engine oil helps deliver excellent all-around performance to Formula 4 cars. Its triple action power has a track record of providing exceptional cleaning power and wear protection both on and off the track
“Mobil’s exceptional expertise and unwavering dedication to innovation seamlessly align with IRF’s mission to deliver extraordinary racing experiences. By integrating Mobil’s superior lubricants and motor oils, we will ensure that our cars perform at their peak, delivering an exhilarating spectacle for our fans while upholding the highest safety standards throughout the Indian Racing Festival season,” said IRF chairman and managing director of Racing Promotions Private Limited (RPPL), promoters Akhilesh Reddy.
Mobil, a flagship brand under ExxonMobil, has a rich history that celebrates its golden 50-year completion in 2024. Over the last 5 decades, Mobil 1 remains the world’s leading synthetic motor oil brand. It has pushed forward the boundaries of automotive lubricant technology, evolving and improving to keep engines running like new, mile after mile, since 1974.
“We are excited to partner with the Indian Racing Festival, a platform that aligns perfectly with our dedication to innovation and performance. With ExxonMobil’s cutting-edge technology and IRF’s unwavering commitment to the Indian motorsports ecosystem, we are confident that this collaboration will elevate performance on the tracks this season and provide drivers and fans with an outstanding experience. We look forward to fueling the excitement and contributing to the success of this premier event,” said ExxonMobil Lubricants PVT LTD CEO Vipin Rana.
Promoted by RPPL, the Indian Racing Festival aims to captivate India’s growing motorsports fanbase with two premier championships: the franchise-based Indian Racing League (IRL) and the Formula 4 Indian Championship (F4IC). Featuring top drivers including men and women from India and around the world, IRL 2024 begins on August 24, followed by India’s first-ever night street circuit race at the Chennai Formula Racing Circuit a week later.
Tickets for Rounds 1 and 2, the latter being the highly-anticipated night street race, are now available on Paytm Insider and it will also be broadcast on Star Sports.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
